Compass Pathways is a biotechnology company developing investigational psilocybin treatments for conditions such as treatment-resistant depression, post-traumatic stress disorder, and anorexia nervosa. By focusing on evidence-based therapies, the company aims to improve patient access to effective mental health care solutions.
Funding
$150M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Current treatments for mental health conditions like treatment-resistant depression, post-traumatic stress disorder, and anorexia nervosa often prove ineffective, leaving patients with limited options and persistent suffering. Access to innovative, evidence-based therapies remains a significant barrier for many individuals struggling with these disorders.
Solution
Compass Pathways is developing investigational psilocybin treatments with the goal of improving outcomes for patients with challenging mental health conditions. Their approach focuses on rigorous scientific research and evidence-based therapies to demonstrate safety and efficacy. By exploring the therapeutic potential of psilocybin, Compass Pathways aims to provide clinicians with new tools to address unmet needs in mental health care and expand patient access to effective solutions. The company is currently studying psilocybin treatment for treatment-resistant depression, post-traumatic stress disorder and anorexia nervosa.
Target Audience
The primary target audience includes individuals suffering from treatment-resistant depression, post-traumatic stress disorder, and anorexia nervosa, as well as mental health professionals seeking innovative treatment options.
Features
- Investigational psilocybin therapy for treatment-resistant depression
- Investigational psilocybin therapy for post-traumatic stress disorder
- Investigational psilocybin therapy for anorexia nervosa
- Focus on evidence-based research and clinical trials